WARRANT TO PURCHASE ORDINARY SHARES OF STRONGBRIDGE BIOPHARMA PLC Dated as of May 19, 2020 (the “Issue Date”) Void after the date specified in Section 8Strongbridge Biopharma PLC • August 4th, 2020 • Pharmaceutical preparations • New York
Company FiledAugust 4th, 2020 Industry Jurisdiction
FORM OF WARRANTStrongbridge Biopharma PLC • March 12th, 2018 • Pharmaceutical preparations • New York
Company FiledMarch 12th, 2018 Industry JurisdictionTHIS CERTIFIES THAT, for value received, [__], or its registered assigns (the “Holder”), is entitled, subject to the provisions and upon the terms and conditions set forth herein, to purchase from STRONGBRIDGE BIOPHARMA PLC, a public limited company incorporated under the laws of Ireland (the “Company”), that number of shares (the “Shares”) of the Company’s ordinary shares, of nominal value $0.01 per share (the “Ordinary Shares”), at such times and at the price per Share, set forth in Section 1. The term “Warrant” as used herein shall include this Warrant and any warrants delivered in substitution or exchange therefor as provided herein. This Warrant is issued in connection with the transactions described in the Term Loan Agreement, dated as of July 14, 2017, and amended as of January 16, 2018, by and between the Company, the Subsidiary Guarantors from time to time party thereto, the Lenders from time to time party thereto and CRG Servicing LLC.